A possible first case of COVID recurrence after ensitrelvir: a vaccinated woman whose antigen levels fall and then rebound, with symptoms returning 1 day after treatment.

New research reveals a potentially effective COVID-19 pill is in the works. Here’s what infectious disease experts want you ...

A deadly hantavirus outbreak on a cruise ship has revived bitter memories of when Covid-19 first emerged, but health experts have emphasised the two viruses are very different -- and have sought to ...

Long COVID is a serious, growing public health crisis. Though estimates vary, as many as 18 million Americans may be affected. This is why it continues to capture the attention of Senator Todd Young, ...

Given that nearly everyone in the United States is believed to have had COVID, the 16 percent rate extrapolated to the ...

A deadly hantavirus outbreak on a cruise ship has revived bitter memories of when COVID-19 first emerged, but health experts have emphasized the two viruses are very different—and have sought to ...

The combination of nirmatrelvir-ritonavir was not associated with reduced risk for hospitalization or death in high-risk adults with COVID who were previously vaccinated, but researchers observed some ...

Doctors across India are reporting a worrying rise in hip damage among younger adults after the COVID-19 pandemic. Experts say delayed diagnosis, sedentary lifestyles, and excessive steroid use during ...

An experimental oral medication can dramatically lower the risk of getting COVID-19 after an exposure. The new pill, Ensitrelvir, is already approved for use in Japan. Infectious disease experts are ...

Three people have died and five other cases have been reported following a hantavirus outbreak linked to the MV Hondius cruise ship.

Patients with systemic autoimmune rheumatic disease demonstrate an increased persistence of SARS-CoV-2 antigen positivity up ...